Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms

Challenges for achieving safe and effective radical cure of Plasmodium vivax: a round table discussion of the APMEN Vivax Working Group

(2017) Kamala Thriemer et al.   MALARIA JOURNAL

Burden and impact of Plasmodium vivax in pregnancy: A multi-centre prospective observational study

(2017) Azucena Bardají et al.   PLoS Neglected Tropical Diseases

Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia

(2017) Geraldine M Clarke et al.   eLife

Global Epidemiology of Plasmodium vivax

(2016) Rosalind E. Howes et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis

(2016) Hannah Blencowe et al.   Lancet Global Health

Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group

(2015)   MALARIA JOURNAL

Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report

(2013) Lorenz von Seidlein et al.   MALARIA JOURNAL

Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria

(2013) Jason W. Bennett et al.   NEW ENGLAND JOURNAL OF MEDICINE

Randomized, Open-Label Trial of Primaquine against Vivax Malaria Relapse in Indonesia

(2012) Inge Sutanto et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based Map

(2012) Rosalind E. Howes et al.   PLOS MEDICINE

Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales

(2009) Johanna Sistonen et al.   Pharmacogenetics and Genomics